LICENSE AGREEMENT between ABBVIE IRELAND UNLIMITED COMPANY and CHINOOK THERAPEUTICS U.S., INC. Dated as of December 16, 2019License Agreement • July 22nd, 2020 • Aduro Biotech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 22nd, 2020 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made and entered into effective as of December 16, 2019 (the “Effective Date”) by and between AbbVie Ireland Unlimited Company (“Licensor”) and Chinook Therapeutics U.S., Inc. a Delaware corporation, having a principal place of business at 1600 Fairview Ave. E., Seattle, WA 98102 (“Licensee”). Licensor and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”